there is a new antiviral that are made by shionogi that's being studied and we're very excited about that one because it drops the yucky taste aging component of paxlovid, which is called ritonavir and also ritonavir can have drug drug interactions with other medications. so i'm really excited about this new protease inhibitor that's being studied. and there's also another nucleoside analog. and i think this time next winter we're going to have two more oral pills that you can use for covid . >> all right. that's all good news for those who don't like that metallic taste, that paxlovid tends to have. dr. monica gandhi, always great talking with you. thank you so much. >> thank you. >> next, has the future of transportation stalled? for the second time in as many weeks, a cruise driverless car was involved in a collision in san francisco. ahead, a civil engineer at cal who focuses on transportation technology. we'll talk us talk to us about the top safety issues involving robo taxis. >> when you drive america's best light duty pickup, summer is yours for the taking to take bigger toys